Related references
Note: Only part of the references are listed.Coordination of bismuth and lead in porphyrins: Towards an in-situ generator for α-radiotherapy?
Zakaria Halime et al.
BIOCHIMIE (2009)
Multimodality therapy: Potentiation of high linear energy transfer radiation with paclitaxel for the treatment of disseminated peritoneal disease
Diane E. Milenic et al.
CLINICAL CANCER RESEARCH (2008)
Targeted α-particle radiotherapy with 211At-labeled monoclonal antibodies
Michael R. Zalutsky et al.
NUCLEAR MEDICINE AND BIOLOGY (2007)
212Pb@C60 and its water-soluble derivatives:: Synthesis, stability, and suitability for radioimmunotherapy
Michael D. Diener et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Potentiation of high-LET radiation by gemcitabine: Targeting HER2 with trastuzumab to treat disseminated peritoneal disease
Diane E. Milenic et al.
CLINICAL CANCER RESEARCH (2007)
Synthesis, characterization, and X-ray crystal structures of cyclam derivatives. 8. Thermodynamic and kinetic appraisal of lead(II) chelation by octadentate carbamoyl-armed macrocycles
F Cuenot et al.
INORGANIC CHEMISTRY (2005)
Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator
FM Su et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
α-particle radioimmunotherapy of disseminated peritoneal disease using a 212Pb-labeled radioimmunoconjugate targeting HER2
DE Milenic et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2005)
Melanoma therapy via peptide-targeted α-radiation
YB Miao et al.
CLINICAL CANCER RESEARCH (2005)
Purification of cyclotron-produced 203Pb for labeling Herceptin
K Garmestani et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
Combined 90yttrium-DOTA-labeled PAM4 antibody radioimmunotherapy and gemcitabine radiosensitization for the treatment of a human pancreatic cancer xenograft
DV Gold et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Targeted alpha therapy for cancer
BJ Allen et al.
PHYSICS IN MEDICINE AND BIOLOGY (2004)
Antibody-targeted radiation cancer therapy
DE Milenic et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Structural effects of the lone pair on lead(II), and parallels with the coordination geometry of mercury(II). Does the lone pair on lead(II) form H-bonds? Structures of the lead(II) and mercury(II) complexes of the pendant-donor macrocycle DOTAM (1,4,7,10-tetrakis(carbamoylmethyl)-1,4,7,10-tetraazacyclododecane)
RD Hancock et al.
INORGANIC CHEMISTRY (2004)
Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N′,N,N′-tetraacetic acid for radiolabeling proteins
LL Chappell et al.
NUCLEAR MEDICINE AND BIOLOGY (2003)
In vivo comparison of macrocyclic and acyclic ligands for radiolabeling of monoclonal antibodies with 177Lu for radioimmunotherapeutic applications
DE Milenic et al.
NUCLEAR MEDICINE AND BIOLOGY (2002)
Combined modality radioimmunotherapy - Promise and peril
PA Burke et al.
CANCER (2002)
Radiation doses to non-Hodgkin's lymphoma cells and normal bone marrow exposed in vitro.: Comparison of an α-emitting radioimmunoconjugate and external γ-irradiation
E Aurlien et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2002)
A 212Pb generator based on a 228Th source
S Hassfjell
APPLIED RADIATION AND ISOTOPES (2001)
Theoretical estimation of absorbed dose to organs in radioimmunotherapy using radionuclides with multiple unstable daughters
KA Hamacher et al.
MEDICAL PHYSICS (2001)
The development of the α-particle emitting radionuclides 212Bi and 213Bi, and their decay chain related radionuclides, for therapeutic applications
S Hassfjell et al.
CHEMICAL REVIEWS (2001)
The HER-2/neu oncogene in tumors of the gastrointestinal tract
JS Ross et al.
CANCER INVESTIGATION (2001)
Synthesis, characterization, and evaluation of a novel bifunctional chelating agent for the lead isotopes Pb-203 and Pb-212
LL Chappell et al.
NUCLEAR MEDICINE AND BIOLOGY (2000)
Share Paper
